Gorjan Hrustanovic
Director/Board Member en KYMERA THERAPEUTICS, INC. .
Fortuna: - $ al 29/02/2024
Perfil
Gorjan Hrustanovic occupies the position of Managing Director at BVF Partners LP.
Dr. Hrustanovic is also on the board of Nimbus Therapeutics LLC, Kymera Therapeutics, Inc. and Olema Pharmaceuticals, Inc.
In his past career Dr. Hrustanovic held the position of Member-Observer Board at 4D Molecular Therapeutics, Inc.
Gorjan Hrustanovic received an undergraduate degree from the University of California San Diego and a doctorate from The University of California, San Francisco.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
12/09/2023 | 0 ( -.--% ) | - $ | 29/02/2024 | |
05/01/2024 | 0 ( -.--% ) | - $ | 29/02/2024 |
Cargos activos de Gorjan Hrustanovic
Empresas | Cargo | Inicio |
---|---|---|
KYMERA THERAPEUTICS, INC. | Director/Board Member | 01/03/2020 |
OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 01/07/2018 |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Director/Board Member | - |
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Private Equity Investor | - |
Antiguos cargos conocidos de Gorjan Hrustanovic.
Empresas | Cargo | Fin |
---|---|---|
RAIN ONCOLOGY INC. | Director/Board Member | 25/01/2024 |
4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de Gorjan Hrustanovic.
University of California San Diego | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
KYMERA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Finance |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Olema Pharmaceuticals, Inc. |